Form 4: Castle Biosciences Director Exercises Stock Options
SEC Form 4 Filing
Director Ellen Goldberg exercised stock options, acquiring 440 shares of Castle Biosciences common stock on July 14, 2024.
Summary
- On July 14, 2024, Ellen Goldberg, a director of Castle Biosciences, exercised stock options, acquiring 440 shares of common stock.
- Following the transaction, Goldberg directly owns 18,581 shares of Castle Biosciences.
- The transaction involved the vesting of Restricted Stock Units (RSUs) granted on July 14, 2021, which vest in three equal installments beginning on July 14, 2022.
- Each RSU represents the right to receive one share of Castle Biosciences common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a routine transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure related to insider transactions and provides transparency to the market regarding the holdings of company directors.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it involves a small number of shares relative to the company's total outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 07/14/2021 | Reporting Person was granted 1,320 RSUs which vest in three equal installments beginning on July 14, 2022. |
| 07/14/2022 | First vesting date of RSUs granted on July 14, 2021. |
| 07/14/2024 | Transaction date: Director exercised stock options, acquiring 440 shares. |
| 07/16/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.